Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00725
|
|||||
| Drug Name |
L-citrulline
|
|||||
| Synonyms |
(2S)-2-amino-5-(carbamoylamino)pentanoic acid; (S)-2-Amino-5-ureidopentanoic acid; 2-Amino-5-ureidovaleric acid; 372-75-8; Citrulline; Citrulline, L-; H-cit-oh; L(+)-citrulline; L-(+)-Citrulline; L-2-Amino-5-ureidovaleric acid; L-Cytrulline; L-Ornithine, N5-(aminocarbonyl)-; L-citrullin; N(delta)-Carbamylornithine; N5-(Aminocarbonyl)ornithine; N5-Carbamoyl-L-ornithine; N5-carbamoylornithine; Ornithine, N5-(aminocarbonyl)-; Sitrulline; alpha-Amino-delta-ureidovaleric acid; d-ureidonorvaline; delta-Ureidonorvaline
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Congenital heart defects [ICD11: LA8Z] | Phase 3 | [1] | |||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C6H13N3O3
|
|||||
| Canonical SMILES |
C(CC(C(=O)O)N)CNC(=O)N
|
|||||
| InChI |
InChI=1S/C6H13N3O3/c7-4(5(10)11)2-1-3-9-6(8)12/h4H,1-3,7H2,(H,10,11)(H3,8,9,12)/t4-/m0/s1
|
|||||
| InChIKey |
RHGKLRLOHDJJDR-BYPYZUCNSA-N
|
|||||
| CAS Number |
CAS 372-75-8
|
|||||
| Pharmaceutical Properties | Molecular Weight | 175.19 | Topological Polar Surface Area | 118 | ||
| Heavy Atom Count | 12 | Rotatable Bond Count | 5 | |||
| Hydrogen Bond Donor Count | 4 | Hydrogen Bond Acceptor Count | 4 | |||
| XLogP |
-4.3
|
|||||
| PubChem CID | ||||||
| PubChem SID |
103590387
, 103822856
, 104179172
, 104321397
, 11532235
, 117541475
, 117688788
, 118262351
, 124570894
, 126523666
, 126596840
, 126596898
, 126630014
, 126656479
, 129129178
, 131542198
, 132523304
, 134974821
, 135650512
, 137003163
, 137237572
, 140948627
, 142367638
, 15195082
, 15219582
, 24892975
, 26716699
, 26754401
, 29203971
, 29228316
, 3132518
, 3621
, 46506583
, 47291304
, 50069751
, 51092003
, 57325798
, 57580897
, 57580924
, 75891871
, 7886615
, 81044522
, 8144684
, 8157014
, 821526
, 824126
, 85164881
, 87565504
, 92297486
, 92712847
|
|||||
| ChEBI ID |
CHEBI:16349
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | BAT1 | Transporter Info | Glycoprotein-associated amino acid transporter b0, +AT1 | Substrate | [2] | |
| References | ||||||
| 1 | ClinicalTrials.gov (NCT00335244) Intravenous L-Citrulline to Treat Children Undergoing Heart Bypass Surgery | |||||
| 2 | Transport characteristics of L-citrulline in renal apical membrane of proximal tubular cells. Biopharm Drug Dispos. 2009 Apr;30(3):126-37. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.